Search Results - "Werf, S. van der"

Refine Results
  1. 1

    Pathogen-based precision medicine for drug-resistant tuberculosis by Gröschel, Matthias I, Walker, Timothy M, van der Werf, Tjip S, Lange, Christoph, Niemann, Stefan, Merker, Matthias

    Published in PLoS pathogens (01-10-2018)
    “…[...]mutations can be used to predict different treatment outcomes. [...]by also considering phylogenetic benign mutations that do not confer resistance, a…”
    Get full text
    Journal Article
  2. 2

    Susceptibility of Clinical Mycobacterium tuberculosis Isolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480 by ALFFENAAR, J. W. C, VAN DER LAAN, T, SIMONS, S, VAN DER WERF, T. S, VAN DE KASTEELE, P. J, DE NEELING, H, VAN SOOLINGEN, D

    Published in Antimicrobial Agents and Chemotherapy (01-03-2011)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3

    Sensitivity and specificity of routine diagnostic work-up for tuberculosis in lung clinics in Yogyakarta, Indonesia: a cohort study by Saktiawati, Antonia Morita I, Subronto, Yanri W, Stienstra, Ymkje, Sumardi, Supit, Fabiola, van der Werf, Tjip S

    Published in BMC public health (02-04-2019)
    “…Establishing a correct diagnosis is challenging. We aimed to investigate the sensitivity and specificity of routine tuberculosis (TB) diagnostic work-up in…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis by Alffenaar, J. W. C., van Altena, R., Bökkerink, H. J., Luijckx, G. J., van Soolingen, D., Aarnoutse, R. E., van der Werf, T. S.

    Published in Clinical infectious diseases (01-10-2009)
    “…Moxifloxacin cerebrospinal fluid (CSF) penetration was evaluated by obtaining full plasma and CSF time concentration curves for 4 patients with tuberculous…”
    Get full text
    Journal Article
  5. 5

    Therapeutic vaccines for tuberculosis—A systematic review by Gröschel, Matthias I, Prabowo, Satria A, Cardona, Père-Joan, Stanford, John L, Werf, Tjip S van der

    Published in Vaccine (30-05-2014)
    “…Highlights • We identified 5 potential therapeutic TB vaccines—Mycobacterium vaccae, RUTI, Mycobacterium smegmatis, Mycobacterium indicus pranii and V5. • M…”
    Get full text
    Journal Article
  6. 6

    Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I by Kalkman, J S, Schillings, M L, van der Werf, S P, Padberg, G W, Zwarts, M J, van Engelen, B G M, Bleijenberg, G

    “…Objective: To assess the prevalence of severe fatigue and its relation to functional impairment in daily life in patients with relatively common types of…”
    Get full text
    Journal Article
  7. 7

    Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations by Encalada Ventura, M A, van Wanrooy, M J P, Span, L F R, Rodgers, M G G, van den Heuvel, E R, Uges, D R A, van der Werf, T S, Kosterink, J G W, Alffenaar, J W C

    Published in Antimicrobial agents and chemotherapy (01-05-2016)
    “…Voriconazole (VCZ) exhibits great inter- and intrapatient variability. The latter variation cannot exclusively be explained by concomitant medications, liver…”
    Get full text
    Journal Article
  8. 8

    Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review by Kroesen, Vera M, Gröschel, Matthias I, Martinson, Neil, Zumla, Alimuddin, Maeurer, Markus, van der Werf, Tjip S, Vilaplana, Cristina

    Published in Frontiers in immunology (30-06-2017)
    “…Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional tuberculosis treatment, complicated by emerging drug resistances…”
    Get full text
    Journal Article
  9. 9

    Mycobacterium ulcerans disease by VAN DER WERF, Tjip S, STIENSTRA, Ymkje, ASIEDU, Kingsley, JOHNSON, R. Christian, PHILLIPS, Richard, ADJEI, Ohene, FLEISCHEJ, Bernhard, WANSBROUGH-JONES, Mark H, JOHNSON, Paul D. R, PORTAELS, Francoise, VAN DER GRAAF, Winene T. A

    Published in Bulletin of the World Health Organization (01-10-2005)
    “…Mycobacterium ulcerans disease (Buruli ulcer) is an important health problem in several west African countries. It is prevalent in scattered foci around the…”
    Get full text
    Journal Article
  10. 10

    Pharmacokinetics of Rifampin and Clarithromycin in Patients Treated for Mycobacterium ulcerans Infection by Alffenaar, J W C, Nienhuis, W A, de Velde, F, Zuur, A T, Wessels, A M A, Almeida, D, Grosset, J, Adjei, O, Uges, D R A, van der Werf, T S

    Published in Antimicrobial Agents and Chemotherapy (01-09-2010)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Stigma among healthcare workers towards hepatitis B infection in Bangalore, India: a qualitative study by van der Scheun, F C, Nagelkerke, M C M, Kilaru, A, Shridhar, V, Prasad, R, van der Werf, T S

    Published in BMC health services research (22-10-2019)
    “…With about 50 million people infected with hepatitis B (HBV) in India the burden of disease is high. Stigma has been identified to have a major negative impact…”
    Get full text
    Journal Article
  13. 13

    Mycobacterium ulcerans infection by Van der Werf, Tjip S, Van der Graaf, Winette TA, Tappero, Jordan W, Asiedu, Kingsley

    Published in The Lancet (British edition) (18-09-1999)
    “…After tuberculosis and leprosy, Buruli-ulcer disease(caused by infection with Mycobacterium ulcerans)is the third most common mycobacterial disease in…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection by Nienhuis, Willemien A., Stienstra, Ymkje, Abass, K. Mohammed, Tuah, Wilson, Thompson, William A., Awuah, Peter C., Awuah-Boateng, Nana Yaa, Adjei, Ohene, Bretzel, Gisela, Schouten, Jan P., van der Werf, Tjip S.

    Published in Clinical infectious diseases (15-02-2012)
    “…Background. Antimicrobial killing in mycobacterial infections may be accompanied by (transient) clinical deterioration, known as paradoxical reaction. To…”
    Get full text
    Journal Article
  16. 16

    Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms by Altenburg, J, de Graaff, C S, van der Werf, T S, Boersma, W G

    Published in Respiration (01-01-2011)
    “…Macrolide antibiotics are well known for their antibacterial and anti-inflammatory properties. This article provides an overview of the biological mechanisms…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Voriconazole metabolism is influenced by severe inflammation: a prospective study by Veringa, Anette, Ter Avest, Mendy, Span, Lambert F R, van den Heuvel, Edwin R, Touw, Daan J, Zijlstra, Jan G, Kosterink, Jos G W, van der Werf, Tjip S, Alffenaar, Jan-Willem C

    Published in Journal of antimicrobial chemotherapy (01-01-2017)
    “…During an infection or inflammation, several drug-metabolizing enzymes in the liver are down-regulated, including cytochrome P450 iso-enzymes. Since…”
    Get full text
    Journal Article
  20. 20